Back
 
   
 

Statements of changes in equity
for the year ended 30 September 2009

   
 
            GROUP            
  Notes   Share  
capital  
and  
premium  
Rm  
Share-  
based  
payment  
reserves  
Rm  
Treasury  
shares  
Rm  
Invest-  
ment  
fair  
value  
reserve  
Rm  
Equity  
trans-  
action  
with BEE  
partner  
Rm  
Non-  
distribu-  
table  
reserves  
Rm  
Retained  
earnings  
Rm  
Attribu-  
table to  
equity  
holders  
of  
Reunert  
Limited  
Rm  
Minority  
interest  
Rm  
Total  
Rm  
Balance at 30 September 2007     90,8   649,9   (276,1)  —   —   7,3   1 997,1   2 469,0   14,4   2 483,4  
Reunert share of equity accounted associate’s actuarially valued surplus of medical aid provision transferred to retained income               (3,9)  3,9   —     —  
Foreign currency translation reserve   23             0,7     0,7     0,7  
Fair valuation of financial instrument – investment in NSN   14, 15, 22         660,3         660,3     660,3  
Deferred taxation on fair value gain   14, 15, 22         (39,2)        (39,2)    (39,2) 
Purchase of a portion of BEE partner’s interest in a subsidiary   5, 22           (35,3)      (35,3)    (35,3) 
Net income recognised directly in equity     —   —   —   621,1   (35,3)  (3,2)  3,9   586,5   —   586,5  
Profit for the year                 1 156,6   1 156,6   7,1   1 163,7  
Total recognised income and expense for the year     —   —   —   621,1   (35,3)  (3,2)  1 160,5   1 743,1   7,1   1 750,2  
Share-based payment expense   2, 21     14,4             14,4     14,4  
Dividends declared and paid   8               (567,2)  (567,2)  (1,8)  (569,0) 
Issue of shares – share capital   21   0,1               0,1     0,1  
                          – share premium   21   16,0               16,0     16,0  
Minority interest introduced                     1,0   1,0  
Balance at 30 September 2008     106,9   664,3   (276,1)  621,1   (35,3)  4,1   2 590,4   3 675,4   20,7   3 696,1  
Foreign currency translation reserve   23             (0,9)    (0,9)    (0,9) 
Fair valuation adjustment of financial instrument – investment in NSN   15, 22         (311,7)        (311,7)    (311,7) 
Deferred taxation on fair value adjustment   15, 22         39,2         39,2     39,2  
Fair valuation of financial instrument – interest rate swap   22         (10,2)        (10,2)    (10,2) 
Net income recognised directly in equity     —   —   —   (282,7)  —   (0,9)  —   (283,6)  —   (283,6) 
Profit for the year                 1 164,5   1 164,5   9,0   1 173,5  
Total recognised income and expense for the year     —   —   —   (282,7)  —   (0,9)  1 164,5   880,9   9,0   889,9  
Share-based payment expense   2, 21     15,0             15,0     15,0  
Deferred tax on share-based payment expense   17     0,3             0,3     0,3  
Dividends declared and paid   8               (546,3)  (546,3)  (4,0)  (550,3) 
Issue of shares – share capital*   21   —               —     —  
                          – share premium   21   9,1               9,1     9,1  
Net minority interest introduced                   —   1,0   1,0  
Transfer to reserves               8,7   (8,7)  —     —  
Balance at 30 September 2009     116,0   679,6   (276,1)  338,4   (35,3)  11,9   3 199,9   4 034,4   26,7   4 061,1  
* Nil due to rounding                        
                       
    COMPANY  
  Notes   Share  
capital  
and  
premium  
Rm  
Share-  
based  
payment  
reserves  
Rm  
Invest-  
ment  
fair  
value  
reserve  
Rm  
Non-  
distribu-  
table  
reserves  
Rm  
Retained  
earnings  
Rm  
Total  
Rm  
Balance at 30 September 2007     90,8   625,8   —   0,3   2 057,3   2 774,2  
Fair valuation of financial instrument – investment in NSN         647,5       647,5  
Deferred taxation on fair value gain         (39,2)      (39,2) 
Net income recognised directly in equity     —   —   608,3   —   —   608,3  
Net profit for the year             831,0   831,0  
Total recognised income and expense for the year     —   —   608,3   —   831,0   1 439,3  
Share-based payment expense   2, 5, 21     7,6         7,6  
Dividends declared and paid   8           (626,2)  (626,2) 
Issue of shares – share capital   21   0,1           0,1  
                          – share premium   21   16,0           16,0  
Balance at 30 September 2008     106,9   633,4   608,3   0,3   2 262,1   3 611,0  
Fair valuation adjustment of financial instrument – investment in NSN         (311,7)      (311,7) 
Deferred taxation on fair value adjustment         39,2       39,2  
Net income recognised directly in equity     —   —   (272,5)  —   —   (272,5) 
Net profit for the year             974,6   974,6  
Total recognised income and expense for the year     —   —   (272,5)  —   974,6   702,1  
Share-based payment expense   2, 5, 21     4,0         4,0  
Dividends declared and paid   8           (602,9)  (602,9) 
Issue of shares – share capital*   21   —           —  
                          – share premium   21   9,1           9,1  
Balance at 30 September 2009     116,0   637,4   335,8   0,3   2 633,8   3 723,3  
* Nil due to rounding